Home Newsfeeds HC Wainwright & Co. Reiterates Buy on Day One Biopharmaceutical, Maintains $45 Price Target

HC Wainwright & Co. Reiterates Buy on Day One Biopharmaceutical, Maintains $45 Price Target

HC Wainwright & Co. analyst Andres Maldonado reiterates Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and maintains $45 price target.

byBenzinga Newsdesk

March 7, 2023

1 minute read

HC Wainwright & Co. analyst Andres Maldonado reiterates Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and maintains $45 price target.

FTX Pushes To Nullify Value Of ‘Sam Coins’ Amid Bankruptcy Proceedings

By Mehab Qureshi

March 27, 4:56 AM

The troubled cryptocurrency exchange FTX is currently pushing to nullify the value of certain tokens tied to its founder, Sam Bankman-Fried, in an ongoing bankruptcy trial.

BTC

FingerMotion Files Federal Lawsuit Against Short Selling Research Firm

By Benzinga Newsdesk

October 20, 9:03 AM

FingerMotion, Inc. (NASDAQ:FNGR) (the "Company" or "FingerMotion"), a mobile services and data company, announces that a federal lawsuit has been filed against Capybara Research ("Capybara") in the United States District

FNGR

Gilbert Family Foundation Launches Venture 313, Building On Support Of Detroit’s Entrepreneurial Ecosystem

By Adam Eckert

September 8, 12:00 PM

The Gilbert Family Foundation on Thursday announced the launch of Venture 313, a three-year, $10 million commitment that will help fulfill Detroit’s entrepreneurial potential and provide founders with opportunities to participate in the innovation economy.

RKT

Why T2 Biosystems Stock Fell Today

By Ryan Gustafson

September 19, 5:52 PM

T2 Biosystems, Inc. (NASDAQ: TTOO) shares traded lower Tuesday as the stock pulled back following Monday's strength after the FDA cleared the company's biothreat panel for commerci

TTOO

HC Wainwright & Co. Reiterates Buy on Day One Biopharmaceutical, Maintains $45 Price Target

Related Posts

FTX Pushes To Nullify Value Of ‘Sam Coins’ Amid Bankruptcy Proceedings

FingerMotion Files Federal Lawsuit Against Short Selling Research Firm

Gilbert Family Foundation Launches Venture 313, Building On Support Of Detroit’s Entrepreneurial Ecosystem

Why T2 Biosystems Stock Fell Today